TP53 and prostate carcinoma: The illustrations in Figure 3, Figure 4 and Figure 5 collectively highlight the prognostic and predictive roles of PTEN, RB1, and TP53 gene alterations, respectively, across prostate cancer stages, emphasizing their influence on treatment sensitivity, resistance mechanisms, and survival outcomes.